title: Regadenoson-induced bradycardia and hypotension: possible mechanism and antidote.
authors.affiliation: Imperial College London, London, United Kingdom, srunderwood@imperial.ac.uk.
authors.forename: S R
authors.initials: SR
authors.lastname: Underwood
authors.forename: K A
authors.initials: KA
authors.lastname: Latus
authors.forename: E
authors.initials: E
authors.lastname: Reyes
authors.forename: K
authors.initials: K
authors.lastname: Standbridge
authors.forename: S
authors.initials: S
authors.lastname: Walker
authors.forename: K
authors.initials: K
authors.lastname: Wechalekar
mesh_terms: D058908:Adenosine A2 Receptor Agonists / Q000009:adverse effects; D000931:Antidotes / Q000627:therapeutic use; D001285:Atropine / Q000627:therapeutic use*; D001919:Bradycardia / Q000139:chemically induced* / Q000517:prevention & control; D005080:Exercise Test / Q000009:adverse effects*; D006801:Humans; D007022:Hypotension / Q000139:chemically induced* / Q000517:prevention & control; D011687:Purines / Q000009:adverse effects* / Q000037:antagonists & inhibitors*; D011720:Pyrazoles / Q000009:adverse effects* / Q000037:antagonists & inhibitors*; D014665:Vasodilator Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors
chemical_list: D058908:Adenosine A2 Receptor Agonists; D000931:Antidotes; D011687:Purines; D011720:Pyrazoles; D014665:Vasodilator Agents; C430916:regadenoson; D001285:Atropine